CAS: 1472795-20-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | KRCA-0008 REF: AN-AG00ABKJCAS: 1472795-20-2 | 98+% | 65,00 €~199,00 € | Lun 13 May 24 |
 | KRCA-0008 REF: TM-T2641CAS: 1472795-20-2 | 96.19% | 46,00 €~402,00 € | Mar 21 May 24 |
 | KRCA 0008 REF: 3D-XIC79520CAS: 1472795-20-2 | Min. 95% | A consultar | Mar 25 Jun 24 |
Ref: AN-AG00ABKJ
| 10mg | 65,00 € | |
| 25mg | 105,00 € | |
| 50mg | 174,00 € | |
| 100mg | 199,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
KRCA-0008
CAS:1472795-20-2
KRCA-0008 is an effective and specific ALK/Ack1 inhibitor (IC50: 12/4 nM); displays drug-like properties without …
Fórmula:
C30H37ClN8O4
Pureza:
96.19%
Forma y color:
Solid
Peso molecular:
609.12
Ref: TM-T2641
| 5mg | 46,00 € | |
| 10mg | 74,00 € | |
| 25mg | 124,00 € | |
| 50mg | 237,00 € | |
| 100mg | 402,00 € | |
| 1ml*10 (DMSO) | 57,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
KRCA 0008
CAS:1472795-20-2
KRCA 0008 is a molecule that activates the function of an enzyme called tyrosine kinase. …
Fórmula:
C30H37ClN8O4
Pureza:
Min. 95%
Peso molecular:
609.12 g/mol
Ref: 3D-XIC79520
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 25 de Junio de 2024
